Kemal Sonmez

Kemal Sonmez

Auto-generated profile, based on publicly available information

Kemal Sonmez

Cancer Early Detection Advanced Research Center, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 September 2014 in Nature
Verified
Journal Article
Open access
PDF file
LCLucia Carbone
Lucia Carbone
RHR. Alan Harris
R. Alan Harris
SGSante Gnerre
Sante Gnerre
KVKrishna R. Veeramah
Krishna R. Veeramah
BLBelen Lorente-Galdos
Belen Lorente-Galdos
RGRichard A. Gibbs
Richard A. Gibbs
Gibbons are small arboreal apes that display an accelerated rate of evolutionary chromosomal rearrangement and occupy a key node in the primate phylogeny between Old World monkeys and great apes. Here we present the assembly and analysis of a northern white-cheeked gibbon (Nomascus leucogenys) genome. We describe the propensity for a gibbon-specific retrotransposon (LAVA) to insert into chromosome segregation genes and alter transcription by providing a premature termination site, suggesting a possible molecular mechanism for the genome plasticity of the gibbon lineage. We further show that the gibbon genera (Nomascus, Hylobates, Hoolock and Symphalangus) experienced a near-instantaneous radiation ∼5 million years ago, coincident with major geographical changes in southeast Asia that caused cycles of habitat compression and expansion. Finally, we identify signatures of positive selection in genes important for forelimb development (TBX5) and connective tissues (COL1A1) that may have been involved in the adaptation of gibbons to their arboreal habitat.

9 January 2009 in PLOS Computational Biology
Verified
Journal Article
Open access
PDF file
KSKemal Sonmez
Kemal Sonmez
NZNaunihal T. Zaveri
Naunihal T. Zaveri
IKIlan A. Kerman
Ilan A. Kerman
SBSharon Burke
Sharon Burke
CNCharles R. Neal
Charles R. Neal
LTLawrence Toll
Lawrence Toll
There are currently a large number of “orphan” G-protein-coupled receptors (GPCRs) whose endogenous ligands (peptide hormones) are unknown. Identification of these peptide hormones is a difficult and important problem. We describe a computational framework that models spatial structure along the genomic sequence simultaneously with the temporal evolutionary path structure across species and show how such models can be used to discover new functional molecules, in particular peptide hormones, via cross-genomic sequence comparisons. The computational framework incorporates a priori high-level knowledge of structural and evolutionary constraints into a hierarchical grammar of evolutionary probabilistic models. This computational method was used for identifying novel prohormones and the processed peptide sites by producing sequence alignments across many species at the functional-element level. Experimental results with an initial implementation of the algorithm were used to identify potential prohormones by comparing the human and non-human proteins in the Swiss-Prot database of known annotated proteins. In this proof of concept, we identified 45 out of 54 prohormones with only 44 false positives. The comparison of known and hypothetical human and mouse proteins resulted in the identification of a novel putative prohormone with at least four potential neuropeptides. Finally, in order to validate the computational methodology, we present the basic molecular biological characterization of the novel putative peptide hormone, including its identification and regional localization in the brain. This species comparison, HMM-based computational approach succeeded in identifying a previously undiscovered neuropeptide from whole genome protein sequences. This novel putative peptide hormone is found in discreet brain regions as well as other organs. The success of this approach will have a great impact on our understanding of GPCRs and associated pathways and help to identify new targets for drug development. Peptide hormones, or neuropeptides, are made up of a string of amino acids ranging from approximately 3 to 50 residues. These peptides are processed from a larger protein called a prohormone and activate a class of proteins called G-protein-coupled receptors (GPCRs). Neuropeptides signal neurons and other cells leading to changes in cellular biochemistry and potentially gene expression. There are a number of “orphan” GPCRs, i.e., receptors that have been discovered either by genomic sequence or by cloning, in which its respective peptide hormone is unknown. We have devised a computational method that models patterns in protein sequence simultaneously with evolutionary differences across species in order to identify previously unknown peptide hormones. We have used this computational methodology to identify a previously unknown putative prohormone that contains up to four potential neuropeptides, and we have characterized this prohormone with respect to location in rat brain and various human tissues. This computational technique will be useful for the identification of additional neuropeptides and help to characterize orphan GPCRs. Because roughly half of all pharmaceuticals act through activation or inhibition of GPCRs, this technique should lead to the identification of additional pharmaceutical targets and ultimately clinically used drugs.

1 November 2016 in Ophthalmology
Verified
Journal Article
Closed access
JCJ Peter Campbell
J Peter Campbell
JKJayashree Kalpathy-Cramer
Jayashree Kalpathy-Cramer
DEDeniz Erdogmus
Deniz Erdogmus
PTPeng Tian
Peng Tian
DKDharanish Kedarisetti
Dharanish Kedarisetti
ICImaging and Informatics in Retinopathy of Prematurity Research Consortium
Imaging and Informatics in Retinopathy of Prematurity Research Consortium

24 November 2008 in Journal of Neurochemistry
Verified
Journal Article
Open access
PDF file
XZXin Zhang
Xin Zhang
FCFa‐Yun Che
Fa‐Yun Che
IBIryna Berezniuk
Iryna Berezniuk
KSKemal Sonmez
Kemal Sonmez
LTLawrence Toll
Lawrence Toll
LFLloyd D. Fricker
Lloyd D. Fricker
Quantitative peptidomics was used to compare levels of peptides in wild type (WT) and Cpefat/fat mice, which lack carboxypeptidase E (CPE) activity because of a point mutation. Six different brain regions were analyzed: amygdala, hippocampus, hypothalamus, prefrontal cortex, striatum, and thalamus. Altogether, 111 neuropeptides or other peptides derived from secretory pathway proteins were identified in WT mouse brain extracts by tandem mass spectrometry, and another 47 peptides were tentatively identified based on mass and other criteria. Most secretory pathway peptides were much lower in Cpefat/fat mouse brain, relative to WT mouse brain, indicating that CPE plays a major role in their biosynthesis. Other peptides were only partially reduced in the Cpefat/fat mice, indicating that another enzyme (presumably carboxypeptidase D) contributes to their biosynthesis. Approximately 10% of the secretory pathway peptides were present in the Cpefat/fat mouse brain at levels similar to those in WT mouse brain. Many peptides were greatly elevated in the Cpefat/fat mice; these peptide processing intermediates with C-terminal Lys and/or Arg were generally not detectable in WT mice. Taken together, these results indicate that CPE contributes, either directly or indirectly, to the production of the majority of neuropeptides.

28 October 2011 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
LTLawrence Toll
Lawrence Toll
TKTaline V. Khroyan
Taline V. Khroyan
KSKemal Sonmez
Kemal Sonmez
AOAkihiko Ozawa
Akihiko Ozawa
ILIris Lindberg
Iris Lindberg
DKDaniel R. Kapusta
Daniel R. Kapusta
Computational methods have led two groups to predict the endogenous presence of a highly conserved, amidated, 14‐aa neuropeptide called either spexin or NPQ. NPQ/spexin is part of a larger prohormone that contains 3 sets of RR residues, suggesting that it could yield more than one bioactive peptide; however, no in vivo activity has been demonstrated for any peptide processed from this precursor. Here we demonstrate biological activity for two peptides present within proNPQ/spexin. NPQ/spexin (NWTPQAMLYLKGAQ‐NH 2 ) and NPQ 53–70 (FISDQSRRKDLSDRPLPE) have differing renal and cardiovascular effects when administered intracerebroventricularly or intravenously into rats. Intracerebroventricular injection of NPQ/spexin produced a 13 ± 2 mmHg increase in mean arterial pressure, a 38 ± 8 bpm decrease in heart rate, and a profound decrease in urine flow rate. Intracerebroventricular administration of NPQ 53–70 produced a 26 ± 9 bpm decrease in heart rate with no change in mean arterial pressure, and a marked increase in urine flow rate. Intraventricular NPQ/spexin and NPQ 53–70 also produced antinociceptive activity in the warm water tail withdrawal assay in mice (ED 50 <30 and 10 nmol for NPQ/spexin and NPQ 53–70, respectively). We conclude that newly identified peptides derived from the NPQ/spexin precursor contribute to CNS‐mediated control of arterial blood pressure and salt and water balance and modulate nociceptive responses.—Toll, L., Khroyan, T. V., Sonmez, K., Ozawa, A., Lindberg, I., McLaughlin, J. P., Eans, S. O., Shahien, A. A., Kapusta, D. R. Peptides derived from the prohormone proNPQ/spexin are potent central modulators of cardiovascular and renal function and nociception. FASEB J. 26, 947–954 (2012). www.fasebj.org

1 December 2001
Verified
Conference Paper
Closed access
PDF file
SESteven Eker
Steven Eker
MKMerrill Knapp
Merrill Knapp
KLKeith Laderoute
Keith Laderoute
PLPatrick Lincoln
Patrick Lincoln
JMJose Meseguer
Jose Meseguer
KSKemal Sonmez
Kemal Sonmez